Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 MET targeting: perspectives for the radiation oncologist.

Literature DB >> 22869330

MET targeting: perspectives for the radiation oncologist.

Cyrus Chargari, Eric Deutsch.

Abstract

Mesh：

Year: 2012 PMID： 22869330 DOI： 10.1038/nrclinonc.2012.71-c1

Source DB: PubMed Journal: Nat Rev Clin Oncol ISSN： 1759-4774 Impact factor: 66.675

Keyword Cloud
References

× No keyword cloud information.

8 in total

Review 1. Invasive growth: a MET-driven genetic programme for cancer and stem cells.

Authors: Carla Boccaccio; Paolo M Comoglio
Journal: Nat Rev Cancer Date: 2006-08 Impact factor: 60.716

2. The c-Met receptor tyrosine kinase inhibitor MP470 radiosensitizes glioblastoma cells.

Authors: James W Welsh; Daruka Mahadevan; Ron Ellsworth; Laurence Cooke; David Bearss; Baldassarre Stea
Journal: Radiat Oncol Date: 2009-12-22 Impact factor: 3.481

3. Induction of MET by ionizing radiation and its role in radioresistance and invasive growth of cancer.

Authors: Francesca De Bacco; Paolo Luraghi; Enzo Medico; Gigliola Reato; Flavia Girolami; Timothy Perera; Pietro Gabriele; Paolo M Comoglio; Carla Boccaccio
Journal: J Natl Cancer Inst Date: 2011-04-04 Impact factor: 13.506

4. MET inhibition in tumor cells by PHA665752 impairs homologous recombination repair of DNA double strand breaks.

Authors: Michaela Medová; Daniel M Aebersold; Yitzhak Zimmer
Journal: Int J Cancer Date: 2011-05-09 Impact factor: 7.396

5. Radiosensitization of glioma cells by modulation of Met signalling with the hepatocyte growth factor neutralizing antibody, AMG102.

Authors: Ian M Buchanan; Tamalee Scott; Anita T Tandle; William E Burgan; Teresa L Burgess; Philip J Tofilon; Kevin Camphausen
Journal: J Cell Mol Med Date: 2010-07-12 Impact factor: 5.310

MET targeting: perspectives for the radiation oncologist.

Review 1. Invasive growth: a MET-driven genetic programme for cancer and stem cells.

2. The c-Met receptor tyrosine kinase inhibitor MP470 radiosensitizes glioblastoma cells.

3. Induction of MET by ionizing radiation and its role in radioresistance and invasive growth of cancer.

4. MET inhibition in tumor cells by PHA665752 impairs homologous recombination repair of DNA double strand breaks.

5. Radiosensitization of glioma cells by modulation of Met signalling with the hepatocyte growth factor neutralizing antibody, AMG102.

6. Hypoxia promotes invasive growth by transcriptional activation of the met protooncogene.

Review 7. MET: a promising anticancer therapeutic target.

Review 8. Phosphatidylinositide 3-kinase/AKT in radiation responses.